维普中文期刊产品整合服务
45篇 您的检索式:作者名="Rodvold KA"
    题名 作者 年代 出处 被引量
1Doxorubicin clearance in the obese显示文摘Rodvold KA Rushing DA Tewksbury DA 0,,:1
2Pharmacokinetics and pharmacodynamics of fluoroquinolones显示文摘 Neuhauser M 2001Pharmacotherapy2001,21,:1
3Daptomycin:A novel cyclic li- popeptide antimicrobial 显示文摘Schriever CA Fernandez C Rodvold KA 2005Clinical Review2005,62,11:1
4Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination显示文摘Schoonover LL Occhipinti DJ Rodvold KA 1995Ann Pharmacother1995,29,5:1
5Pharmaeodynamic profiling of piperacillin in the prsence of tazobaetam in patients through the use of population phanmcokinetic modds and monte carlo simulation 显示文摘Lodise Jr TP Lomaestm B Rodvold KA 2004Antimicvob Agents Chemother2004,48,12:1
6Clarithromycin and azithromycin: new macrolide antibiotics 显示文摘Piscitelli SC Danziger LH Rodvold KA 1992Clinical Phar- macy1992,11,2:1
7Daptomycin:a novel cyclic lipopeptide antimicrobial显示文摘Schriever CA Femandez C Rodvold KA 2005Am J Health syst Pharm2005,62,11:1
8The pharmacodynamic and pharmacokinetic differences of the D- and L-isomers of verapamil: implications in the treatment of paroxysmal supraventricular tachycardia 显示文摘HOON TJ BAUMAN JL RODVOLD KA 1986Am Heart J1986,112,2:1
9Vancomycin pharmaeokinetics in patients with various degrees of renal function显示文摘Rodvold KA Blum RA Fischer JH 1988Antimicrob Agents Chemother1988,32,6:1
10Serum,tissue and body fluid concentrations of tigecycline after a single 100 mg dose显示文摘Rodvold KA Gotfried MH Cwik M 2006J Antimicrob Chemother2006,58,6:1
11Daptomycin : a novel cyclic lipopeptide antimicrobial 显示文摘Schriever CA Femandez C Rodvold KA 2005Am J Health Syst Pharm2005,,:1
12Pharmacodynamic profil- ing of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simu- lation显示文摘Lodise TJ Lomaestro B Rodvold KA 2004Antimicrob Agents Chemother2004,48,12:1
13Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects显示文摘Gotfried MH Daziger LH Rodvold KA 2001Chest2001,119,4:1
14Risk factors associated with the development of infection with linezolid-and vancomycin-resistant enterococcus faecium显示文摘Pai MP Rodvold KA Schreckenberger PC 2002Clin Infect Dis2002,35,10:1
15Antibiotic drug interactions显示文摘Pai MP Momary KM Rodvold KA 2006Med Clin North Am2006,90,6:1
16Pharmacokinetics and pharmacodynamics of fluoroquinolones显示文摘 Neuhauser M 2001Pharmacoherapy2001,21,10:1
17Vancomycin: We can' t get there from here显示文摘Patel N Pai MP Rodvold KA 2011Clin lnfect Dis2011,52,8:1
18Doxorubicin clearance inthe obese显示文摘Rodvold KA Rushing DA Tewksbury DA 1988J Clin Oncol1988,6,:1
19Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stew- ardship显示文摘George JM Towne TG Rodvold KA 2012Pharmacotherapy2012,32,8:1
20Clarithromycin and azithromin:new macrolide antibiotics显示文摘Piscitelli SC Danziger LH Rodvold KA 1992Clin Pharmacy1992,11,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费